Results 351 to 360 of about 9,453,577 (435)

AI in Neurology: Everything, Everywhere, All at Once Part 3: Surveillance, Synthesis, Simulation, and Systems

Annals of Neurology, EarlyView.
This final part 3 review builds on the practical applications discussed in part 2 and explores how artificial intelligence (AI) is transforming data management, neurological education, and neurological care across large healthcare networks and datasets. The review also highlights AI's role in real‐world and synthetic data, digital twins, and innovative
Matthew Rizzo
wiley   +1 more source

Differential modulation of movement speed with state-dependent deep brain stimulation in Parkinson’s disease

Cavallo A, Köhler RM, Busch JL, Habets JGV, Merk T, Zvarova P, Vanhoecke J, Binns TS, Al-Fatly B, de Almeida Marcelino AL, Darcy N, Schneider G, Krause P, Horn A, Faust K, Herz DM, Yttri E, Cagnan H, Kühn AA, Neumann W.   +19 more
europepmc   +1 more source

The Exon-Based Transcriptomic Analysis of Parkinson's Disease. [PDF]

Biomolecules
Kõks S.
europepmc   +1 more source

Asymmetric Synthesis of Noradamantane Scaffolds via Diphenylprolinol Silyl Ether‐Mediated Domino Michael/Epimerization/Michael (or Aldol)/1,2‐Addition Reactions

Angewandte Chemie, EarlyView.
Topologically unique, 3D cage‐like noradamantanes are synthesized in one pot from simple starting materials. Catalyzed by diphenylprolinol silyl ether, the reaction followed a domino sequence of Michael/epimerization/Michael/1,2‐addition, achieving excellent enantioselectivity.
Konstantinos Daskalakis, Nariyoshi Umekubo, Satrajit Indu, Genki Kawauchi, Tohru Taniguchi, Kenji Monde, Yujiro Hayashi   +6 more
wiley   +2 more sources

Cholinergic Degeneration and Cognitive Function in Early GBA1‐Related Parkinson's Disease

Annals of Neurology, EarlyView.
Objective The phenotype of patients with Parkinson's disease carrying GBA1 variants (GBA‐PD) suggest similarities to symptomatology associated with early cholinergic system degeneration. Therefore, this study aims to investigate the clinical features and the cholinergic innervation pattern in patients with early GBA‐PD versus those without the GBA1 ...
Sofie Slingerland, Sygrid van der Zee, Giulia Carli, Anne C. Slomp, Emile d'Angremont, Jeffrey M. Boertien, Teus van Laar   +6 more
wiley   +1 more source

Elevated α‐Synuclein Aggregate Levels in the Urine of Patients with Isolated REM Sleep Behavior Disorder and Parkinson's Disease

Annals of Neurology, EarlyView.
Parkinson's disease (PD) is a neurodegenerative disorder characterized by α‐synuclein aggregation in neurons. Recent advances suggest α‐synuclein aggregates could serve as a biomarker for PD and related synucleinopathies. This study used surface‐based fluorescence intensity distribution analysis (sFIDA) to measure α‐synuclein aggregates in urine ...
Laura Müller, Pelin Özdüzenciler, Charlotte Schedlich‐Teufer, Aline Seger, Hannah Jergas, Gereon R. Fink, Dieter Willbold, Michael Sommerauer, Michael T. Barbe, Gültekin Tamgüney   +9 more
wiley   +1 more source

Single-subject network analysis of FDOPA PET in Parkinson’s disease and Psychosis spectrum

Severino M.
europepmc   +1 more source

Narrative Review on Common Traits of Parkinson's Disease and Epilepsy. [PDF]

J Clin Med
Tilz C, Wang-Tilz Y.
europepmc   +1 more source